13D/13G Filings - Dauntless Investment Group, LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-03-18
2:35 pm
Purchase
2025-03-12 13G OKYO Pharma Limited
OKYO
Dauntless Investment Group, LLC 1,999,380
5.900%
1,999,380increase
(New Position)
Filing
History
2025-03-03
1:51 pm
Purchase
2025-02-26 13G AEON Biopharma, Inc.
AEON
Dauntless Investment Group, LLC 108,224
9.700%
108,224increase
(New Position)
Filing
History
2025-02-26
1:46 pm
Purchase
2025-02-18 13G Femasys Inc.
FEMY
Dauntless Investment Group, LLC 1,429,845
5.400%
1,429,845increase
(New Position)
Filing
History